Boston Scientific Operating Lease ROU Assets increased by 0.6% to $495.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.2%, from $426.00M to $495.00M. Over 4 years (FY 2020 to FY 2024), Operating Lease ROU Assets shows relatively stable performance with a -0.5% CAGR.
An increase reflects expansion of office footprint or new lease agreements, while a decrease indicates lease expirations or downsizing.
This asset represents the company's right to use an underlying leased asset, such as office space, over the lease term....
Standard under IFRS 16 and ASC 842 for all companies with significant real estate leases.
non_current_assets_operating_lease_right_of_use_asset| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $411.00M | $415.00M | $435.00M | $424.00M | $400.00M | $388.00M | $386.00M | $399.00M | $445.00M | $446.00M | $439.00M | $430.00M | $416.00M | $426.00M | $449.00M | $448.00M | $492.00M | $495.00M |
| QoQ Change | — | +1.0% | +4.8% | -2.5% | -5.7% | -3.0% | -0.5% | +3.4% | +11.5% | +0.2% | -1.6% | -2.1% | -3.3% | +2.4% | +5.4% | -0.2% | +9.8% | +0.6% |
| YoY Change | — | — | — | — | -2.7% | -6.5% | -11.3% | -5.9% | +11.3% | +14.9% | +13.7% | +7.8% | -6.5% | -4.5% | +2.3% | +4.2% | +18.3% | +16.2% |